Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CEFTAROLINE FOSAMIL Cause Interstitial lung disease? 6 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Interstitial lung disease have been filed in association with CEFTAROLINE FOSAMIL (Teflaro). This represents 0.8% of all adverse event reports for CEFTAROLINE FOSAMIL.

6
Reports of Interstitial lung disease with CEFTAROLINE FOSAMIL
0.8%
of all CEFTAROLINE FOSAMIL reports
0
Deaths
5
Hospitalizations

How Dangerous Is Interstitial lung disease From CEFTAROLINE FOSAMIL?

Of the 6 reports, 5 (83.3%) required hospitalization, and 6 (100.0%) were considered life-threatening.

Is Interstitial lung disease Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CEFTAROLINE FOSAMIL. However, 6 reports have been filed with the FAERS database.

What Other Side Effects Does CEFTAROLINE FOSAMIL Cause?

Off label use (159) Drug ineffective (72) Death (63) Neutropenia (62) Rash (42) Thrombocytopenia (42) Acute kidney injury (40) Pyrexia (32) Treatment failure (30) Agranulocytosis (29)

What Other Drugs Cause Interstitial lung disease?

METHOTREXATE (3,049) RITUXIMAB (2,458) PEMBROLIZUMAB (2,113) PREDNISONE (1,850) CYCLOPHOSPHAMIDE (1,725) NIVOLUMAB (1,538) AMIODARONE (1,421) DOXORUBICIN (1,352) ETANERCEPT (1,267) ADALIMUMAB (1,250)

Which CEFTAROLINE FOSAMIL Alternatives Have Lower Interstitial lung disease Risk?

CEFTAROLINE FOSAMIL vs CEFTAZIDIME CEFTAROLINE FOSAMIL vs CEFTIBUTEN CEFTAROLINE FOSAMIL vs CEFTOLOZANE\TAZOBACTAM CEFTAROLINE FOSAMIL vs CEFTRIAXONE CEFTAROLINE FOSAMIL vs CEFTRIAXONE\CEFTRIAXONE

Related Pages

CEFTAROLINE FOSAMIL Full Profile All Interstitial lung disease Reports All Drugs Causing Interstitial lung disease CEFTAROLINE FOSAMIL Demographics